abstract |
The invention provides a pharmaceutical composition comprising a nucleic acid molecule encoding an FGF21 mutant polypeptide, an FGF21 mutant polypeptide, an FGF21 mutant polypeptide, and a method of treating a metabolic disorder using the nucleic acid, polypeptide or pharmaceutical composition. |